All Stories

  1. Liposomal formulations of novel metal-based complexes exhibiting high antitumor activity against melanoma
  2. Valorization of Thyme Combined with Phytocannabinoids as Anti-Inflammatory Agents for Skin Diseases
  3. Towards a Less Invasive Treatment for Head and Neck Cancer: Initial Evaluation of Gold Nanoparticle-Mediated Photothermal Therapy
  4. Gold nanoparticle-mediated photothermal therapy: Expanding the frontiers of cancer treatment and theragnostics
  5. Metabolism-targeted therapy in NSCLC – A new theranostics inhalation approach using lactate functionalized and selenium-chrysin loaded nanoparticles (SeChry@PUREG4-LA24)
  6. Locust bean gum (LBG) – A potential excipient for inhalation purposes: Excipient characterisation and in vitro and in vivo toxicological evaluation
  7. Novel 8-Hydroxyquinoline-Derived V(IV)O, Ni(II), and Fe(III) Complexes: Synthesis, Characterization, and In Vitro Cytotoxicity Against Tumor Cells
  8. Liposomal nanoformulations of novel copper-based complexes exhibiting antimelanoma activity – In vitro and in vivo validation
  9. A step forward on the in vitro and in vivo validation of rifabutin-loaded liposomes for the management of highly virulent MRSA infections
  10. Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. Int. J. Mol. Sci. 2021, 22, 5289
  11. Combination of gold nanoparticles with near-infrared light as an alternative approach for melanoma management
  12. Exploring the Biological Activity of Phytocannabinoid Formulations for Skin Health Care: A Special Focus on Molecular Pathways
  13. Liposomal Formulation of an Organogold Complex Enhancing Its Activity as Antimelanoma Agent—In Vitro and In Vivo Studies
  14. In Vivo Measurements of Murine Melanoma's Complex Permittivity Between 500 MHz and 8.5 GHz
  15. Gold nanoparticles for photothermal therapy – Influence of experimental conditions on the properties of resulting AuNPs
  16. 3D-printed aerogels as theranostic implants monitored by fluorescence bioimaging
  17. Combining Phototherapy and Gold-Based Nanomaterials: A Breakthrough in Basal Cell Carcinoma Treatment
  18. Rifabutin: a repurposed antibiotic with high potential against planktonic and biofilm staphylococcal clinical isolates
  19. Targeting superficial cancers with gold nanoparticles: a review of current research
  20. Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer
  21. Enhanced Cytotoxicity against a Pancreatic Cancer Cell Line Combining Radiation and Gold Nanoparticles
  22. Role of ionic liquids in ibuprofen-based eutectic systems: Aqueous solubility, permeability, human cytotoxicity, hemolytic activity and anti-inflammatory activity
  23. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors
  24. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil
  25. A Step Forward for the Treatment of Localized Prostate Cancer Using Gold Nanoparticles Combined with Laser Irradiation
  26. Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections
  27. Liposomal Rifabutin – A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant <em>Staphylococcus aureus </em>Infections
  28. Antimicrobial activity of prophage endolysins against critical Enterobacteriaceae antibiotic-resistant bacteria
  29. Rational approach to design gold nanoparticles for photothermal therapy: the effect of gold salt on physicochemical, optical and biological properties
  30. Structural Optimization of Antimycobacterial Azaaurones Towards Improved Solubility and Metabolic Stability
  31. The current role of cannabis and cannabinoids in health: A comprehensive review of their therapeutic potential
  32. Respirable konjac glucomannan microparticles as antitubercular drug carriers: Effects of in vitro and in vivo interactions
  33. Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma
  34. Breast Cancer Brain Metastases: Implementation and Characterization of a Mouse Model Relying on Malignant Cells Inoculation in the Carotid Artery
  35. miR‐21‐5p promotes NASH‐related hepatocarcinogenesis
  36. Cu(II) and Zn(II) Complexes of New 8-Hydroxyquinoline Schiff Bases: Investigating Their Structure, Solution Speciation, and Anticancer Potential
  37. A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma
  38. Experimental Murine Models for Colorectal Cancer Research
  39. Safety of Gold Nanoparticles: From In Vitro to In Vivo Testing Array Checklist
  40. Pluronic® F127 Hydrogel Containing Silver Nanoparticles in Skin Burn Regeneration: An Experimental Approach from Fundamental to Translational Research
  41. Advancing Medicine with Lipid-Based Nanosystems—The Successful Case of Liposomes
  42. Liposomal Delivery of Saquinavir to Macrophages Overcomes Cathepsin Blockade by Mycobacterium tuberculosis and Helps Control the Phagosomal Replicative Niches
  43. Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management
  44. Challenges in delivery of plant actives
  45. Current Insights and Progress in the Clinical Management of Head and Neck Cancer
  46. Metal Coordination and Biological Screening of a Schiff Base Derived from 8-Hydroxyquinoline and Benzothiazole
  47. 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution
  48. Nanoformulation of Seaweed Eisenia bicyclis in Albumin Nanoparticles Targeting Cardiovascular Diseases: In Vitro and In Vivo Evaluation
  49. Melanoma Management: From Epidemiology to Treatment and Latest Advances
  50. Liposomal Delivery of Newly Identified Prophage Lysins in a Pseudomonas aeruginosa Model
  51. How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT
  52. Human Cytotoxicity, Hemolytic Activity, Anti-Inflammatory Activity and Aqueous Solubility of Ibuprofen-Based Ionic Liquids
  53. Biological Thermal Performance of Organic and Inorganic Aerogels as Patches for Photothermal Therapy
  54. New iron(III) anti-cancer aminobisphenolate/phenanthroline complexes: Enhancing their therapeutic potential using nanoliposomes
  55. Liposomal Formulations of a New Zinc(II) Complex Exhibiting High Therapeutic Potential in a Murine Colon Cancer Model
  56. Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
  57. Liposomes as Tools to Improve Therapeutic Enzyme Performance
  58. The Role of Rosmarinic Acid on the Bioproduction of Gold Nanoparticles as Part of a Photothermal Approach for Breast Cancer Treatment
  59. A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics
  60. The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
  61. Highly Specific Blood-Brain Barrier Transmigrating Single-Domain Antibodies Selected by an In Vivo Phage Display Screening
  62. Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma
  63. Microencapsulated Chitosan-Based Nanocapsules: A New Platform for Pulmonary Gene Delivery
  64. miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
  65. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice
  66. A Newfangled Collagenase Inhibitor Topical Formulation Based on Ethosomes with Sambucus nigra L. Extract
  67. Development of a Topical Insulin Polymeric Nanoformulation for Skin Burn Regeneration: An Experimental Approach
  68. Liposomes as Antibiotic Delivery Systems: A Promising Nanotechnological Strategy against Antimicrobial Resistance
  69. GMP-grade nanoparticle targeted to nucleolin downregulates tumor molecular signature, blocking growth and invasion, at low systemic exposure
  70. Therapeutic potential of a copper complex loaded in pH-sensitive long circulating liposomes for colon cancer management
  71. Proof-of-Concept Study of Multifunctional Hybrid Nanoparticle System Combined with NIR Laser Irradiation for the Treatment of Melanoma
  72. Gold-Based Nanoplataform for the Treatment of Anaplastic Thyroid Carcinoma: A Step Forward
  73. Ecotoxicity and Hemolytic Activity of Fluorinated Ionic Liquids
  74. Liposomes as a Nanoplatform to Improve the Delivery of Antibiotics into Staphylococcus aureus Biofilms
  75. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs
  76. Advances in nanotechnology-related strategies against melanoma
  77. RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
  78. Recent Advances in Ionic Liquids and Nanotechnology for Drug Delivery
  79. A Step Forward in Breast Cancer Research: From a Natural-Like Experimental Model to a Preliminary Photothermal Approach
  80. Further Evidence of Possible Therapeutic Uses of Sambucus nigra L. Extracts by the Assessment of the In Vitro and In Vivo Anti-Inflammatory Properties of Its PLGA and PCL-Based Nanoformulations
  81. Synchronous insight of in vitro and in vivo biological activities of Sambucus nigra L. extracts for industrial uses
  82. Preliminary Assays towards Melanoma Cells Using Phototherapy with Gold-Based Nanomaterials
  83. mIR-21 is increased in patients with NASH-associated HCC and contributes to hepatocarcinogenesis in mice with NAFLD
  84. Lipid-based nanosystems for targeting bone implant-associated infections: current approaches and future endeavors
  85. How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models
  86. A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy
  87. The Aquaporin-3-Inhibiting Potential of Polyoxotungstates
  88. If you cannot beat them, join them: Exploring the fruits of the invasive species Carpobrotus edulis (L.) N.E. Br as a source of bioactive products
  89. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection
  90. Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells
  91. Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson’s disease
  92. Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma
  93. Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation
  94. 11th International Meeting of the Portuguese Society for Stem Cells and Cell Therapies
  95. Abstracts of the 55th Congress of the European Societies of Toxicology (EUROTOX 2019) TOXICOLOGY SCIENCE PROVIDING SOLUTIONS
  96. Demonstrating the Safety of Nanoparticles with Persimmon Extract
  97. FRI-278-RIP3-dependent signalling exerts divergent effects on liver steatosis and carcinogenesis in experimental non-alcholic fatty liver disease
  98. Copper Complex Nanoformulations Featuring Highly Promising Therapeutic Potential in Murine Melanoma Models
  99. New Hyaluronic Acid Particles for Longer-Lasting Osteoarthritis Relief
  100. The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis
  101. Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
  102. Development of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic Cancer
  103. α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma
  104. Track analysis of the passage of rhodamine-labeled liposomes across porcine jejunal mucus in a microchannel device
  105. The role of necroptosis in non-alcoholic fatty liver disease-related carcinogenesis
  106. RIP3-dependent signalling contributes to non-alcoholic fatty liver disease-related hepatocarcinogenesis
  107. miRNA-21 ablation protects against liver injury and necroptosis in cholestasis
  108. Lipid Vesicles for Skin Delivery: Evolution from First Generation
  109. Lipid-Based Nanocarriers for the Treatment of Infected Skin Lesions
  110. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery
  111. The selective cytotoxicity of new triazene compounds to human melanoma cells
  112. Umbilical cord tissue–derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing
  113. Lipid-Based Nanocarriers for Cutaneous Leishmaniais and Buruli Ulcer Management
  114. Activation of necroptosis in human and experimental cholestasis
  115. Nanoformulations of a Potent copper-based Aquaporin Inhibitor With Cytotoxic Effect Against Cancer Cells
  116. Nanoformulations of a Triazene Analogue with Specific Affinity to Human Melanoma
  117. Lipid-Based Nanoformulations of Trifluralin Analogs in the Management ofLeishmania InfantumInfections
  118. Human neonatal mesenchymal stem cell spheroids-conditioned medium accelerates skin regeneration
  119. Targeted delivery of paromomycin in murine infectious diseases through association to nano lipid systems
  120. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing
  121. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model
  122. What Makes Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells Superior Immunomodulators When Compared to Bone Marrow Derived Mesenchymal Stromal Cells?
  123. Liposomes versus Lipid Nanoparticles: Comparative Study of Lipid-Based Systems as Oryzalin Carriers for the Treatment of Leishmaniasis
  124. The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis
  125. Targeted Delivery of Transferrin-Conjugated Liposomes to an Orthotopic Model of Lung Cancer in Nude Rats
  126. Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-β-lactam inhibitor of human leukocyte elastase
  127. Generation of liposome aerosols with the Aeroneb Pro and the AeroProbe nebulizers
  128. Atomic Force Microscopy for the Characterization of Proteoliposomes
  129. Synthesis and evaluation of rifabutin analogs against Mycobacterium avium and H37Rv, MDR and NRP Mycobacterium tuberculosis
  130. Inhaled Liposomes–Current Strategies and Future Challenges
  131. Developments on Drug Delivery Systems for the Treatment of Mycobacterial Infections
  132. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis
  133. Radiation sterilization of antibiotic liposome formulations: A case study
  134. Enzymosomes with surface-exposed superoxide dismutase: In vivo behaviour and therapeutic activity in a model of adjuvant arthritis
  135. Liposomal Superoxide Dismutases and Their Use in the Treatment of Experimental Arthritis
  136. Design and characterization of enzymosomes with surface-exposed superoxide dismutase
  137. Therapeutic Efficacy of Liposomal Rifabutin in a Mycobacterium avium Model of Infection
  138. Formulation of l-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release
  139. Biological characterization of L -asparaginase liposomal formulations
  140. Liposomal l-asparaginase: in vitro evaluation